Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta
Clinical trial NCT02479646 · COMPLETED
Trial details
- NCT number
- NCT02479646
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-06-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.